Chemical Biology and Drug Design

FEBRUARY 23, 2024

In the present work, we report that isoliquiritigenin, a bioactive component of licorice roots, attenuates neuroinflammation of a mice model with subarachnoid hemorrhage through inhibition of NF-κB-mediated NLRP3 inflammasome activation. This work suggests that isoliquiritigenin may ameliorate neurological injury of the patients with subarachnoid hemorrhage, as a kind of adjuvant therapy.

Treatment 100

Treatment Therapies Drugs Research 100

Science Daily: Pharmacology News

FEBRUARY 23, 2024

Undersea anchors of ice that help prevent Antarctica's land ice from slipping into the ocean are shrinking at more than twice the rate compared with 50 years ago, research shows. More than a third of these frozen moorings, known as pinning points, have decreased in size since the turn of the century, experts say. Further deterioration of pinning points, which hold in place the floating ice sheets that fortify Antarctica's land ice, would accelerate the continent's contribution to rising sea leve

Research 118

Research 118

Antidote

FEBRUARY 23, 2024

Individuals living with an illness are likely well-versed in the art of discussing difficult topics with their family and friends. However, for those who are considering taking part in a clinical trial, there may be extra questions to consider when sharing their intent to enroll.

Clinical Trials 116

Clinical Trials Trials 116

Drugs.com

FEBRUARY 23, 2024

FRIDAY, Feb. 23, 2024 -- Amid an outbreak of measles at a Florida elementary school, the state's surgeon general has defied federal health guidance and told parents it's up to them whether they want to keep their unvaccinated child home to avoid.

89

89

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Treatment

BioPharma Drive: Drug Pricing

FEBRUARY 23, 2024

The company earned only $3.5 million last year from its Roctavian treatment, far below the $50 million to $150 million range it had forecast eight months ago.

Therapies 120

Therapies Treatment 120

Drugs.com

FEBRUARY 23, 2024

FRIDAY, Feb. 23, 2024 -- A third of trans masculine people who have undergone testosterone therapy and have stopped menstruating are still ovulating, a new study suggests.That means they remain at risk for an unwanted pregnancy, despite the absence.

Therapies 89

Therapies 89

Drugs.com

FEBRUARY 23, 2024

FRIDAY, Feb. 23, 2024 -- Black voters support a ban on menthol cigarettes by a wide margin, refuting claims that such a ban would be strongly opposed by Black Americans, a new survey shows.Black voters support by a 37-point margin the menthol ban.

116

116

Drug Channels

FEBRUARY 23, 2024

Today’s guest post comes from Nicole Grycan, VP of Commercialization at Phil, Inc. Nicole discusses how hubs can improve access and adherence. She outlines four success factors for manufacturers that use a digital hub partner. To learn more, register for Phil's upcoming webinar: Improving Access, Coverage, and GTN with a Digital Hub. Read on for Nicole’s insights.

Drugs 83

Drugs 83

Drugs.com

FEBRUARY 23, 2024

FRIDAY, Feb. 23, 2024 -- An open question for weight-loss drugs like Ozempic, Wegovy and Zepbound has been whether folks will keep the pounds off when they stop taking them.Regular exercise could be the key to quitting the drugs without regaining.

Drugs 111

Drugs 111

SCIENMAG: Medicine & Health

FEBRUARY 23, 2024

Across the globe, more than 39 million people are living with the Human Immunodeficiency Virus (HIV), the virus that causes AIDS, including more than 1.3 million new HIV diagnoses last year.

Virus 70

Virus Therapies 70

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

Drugs.com

FEBRUARY 23, 2024

FRIDAY, Feb. 23, 2024 -- Increasingly, knee replacement surgeries are requiring follow-up operations when post-op complications arise.Now, new research from the University of Texas Southwestern is illuminating whether you might fall into a.

Research 81

Research 81

Cytel

FEBRUARY 23, 2024

Written by Angelo Tinazzi, Nicolas Rouillé, and Sebastià Barceló In the realm of standards management, companies of all sizes are increasingly exploring the potential of metadata repositories (MDR). From protocol development to eCRF, SDTM, and ADaM to Analysis Results, these repositories are being used to speed up study set up and delivery. Sponsors leverage metadata using a framework that involves putting together a data governance team that establishes and pilots company standards, defines rol

Clinical Trials 64

Clinical Trials Government Trials 64

Drugs.com

FEBRUARY 23, 2024

FRIDAY, Feb. 23, 2024 -- Lockdown drills have become a shudder-inducing part of American life, preparing kids to lie low and keep quiet if a gunman chooses to roam their school.But a new study finds these drills help children who’ve been exposed.

105

105

Drug Patent Watch

FEBRUARY 23, 2024

This chart shows the pharmaceutical companies with the most patents in Mexico. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is… The post Which pharmaceutical companies have the most drug patents in Mexico? appeared first on DrugPatentWatch - Make Better Decisions.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceuticals Drugs 59

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Clinical Trials

Drugs.com

FEBRUARY 23, 2024

FRIDAY, Feb. 23, 2024 (HealthDay news) -- Artificial intelligence can match and even outperform human eye doctors in diagnosing and treating glaucoma, a new study finds.The GPT-4 system from OpenAI did as well or better than ophthalmologists in.

Doctors 98

Doctors 98

Drug Patent Watch

FEBRUARY 23, 2024

Annual Drug Patent Expirations for ANJESO Anjeso is a drug marketed by Baudax and is included in one NDA. There are seven patents protecting this drug. Drug patent litigation for… The post New patent expiration for Baudax drug ANJESO appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs Marketing 59

Drugs.com

FEBRUARY 23, 2024

FRIDAY, Feb. 23, 2024 -- Microscopic bits of plastic have been found lodged in tissues in much of the human body, and new research shows they are also infiltrating the placenta.All samples of placental tissue take from 62 women were shown to.

Research 98

Research 98

Drug Patent Watch

FEBRUARY 23, 2024

Annual Drug Patent Expirations for AUVI-Q Auvi-q is a drug marketed by Kaleo Inc and is included in one NDA. It is available from three suppliers. There are twenty-four patents… The post New patent for Kaleo Inc drug AUVI-Q appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs Marketing 59

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Clinical Trials

Drugs.com

FEBRUARY 23, 2024

FRIDAY, Feb. 23, 2024 -- After states legalize the sale of weed for recreational use, on-the-job injuries rise among younger workers, new research shows.U.S. Bureau of Labor statistics for 2006 through 2020 show that legal “recreational marijuana.

Research 98

Research 98

Drug Patent Watch

FEBRUARY 23, 2024

Annual Drug Patent Expirations for AVYCAZ Avycaz is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. There are seven patents protecting… The post New patent for Allergan drug AVYCAZ appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59

Drugs Marketing 59

Drugs.com

FEBRUARY 23, 2024

FRIDAY, Feb. 23, 2024 -- A “universal” antivenom can block the lethal toxins in the venoms of a wide variety of poisonous snakes found in Africa, Asia and Australia, researchers report.The antibody protected mice from the normally deadly venom.

Research 96

Research 96

Agency IQ

FEBRUARY 23, 2024

BY CHELSEY MCINTYRE, PHARMD Although the prevalence of overweight and obesity in Europe exceeds 50%, the EMA does not currently offer guidance to sponsors on investigating the effects of obesity during drug development. Last week, the agency finalized a reflection paper that has been available only in draft form for the past six years. The paper reaffirms the importance of obesity to drug disposition but offers little in the way of recommendations and guidance to sponsors.

Drugs 59

Drugs Drug Development 59

Drugs.com

FEBRUARY 23, 2024

FRIDAY, Feb. 23, 2024 -- Toddlers who are really into their food might have a higher risk of developing an eating disorder once they enter adolescence, a new study shows.Kids ages 4 and 5 with a strong urge to eat when teased with tasty food appear.

87

87

Agency IQ

FEBRUARY 23, 2024

BY WALKER LIVINGSTON, ESQ The Office of Information and Regulatory Affairs (OIRA) has completed its review of the Safer Communities by Chemical Accident Prevention rule that would amend some of the agency’s risk management program procedures for facilities to focus on protecting vulnerable communities. Under Section 112(r) of the Clean Air Act, the EPA must publish regulations and guidance regarding chemical accident protection at facilities nationwide.

Regulations 59

Regulations 59

Vial

FEBRUARY 23, 2024

In 2022, the global market value of patient portals within the clinical research and healthcare industries was estimated to be US $2.9 billion and is expected to climb at a compound annual growth rate (CAGR) of 19.44% between 2023 and 2030. A number of factors are contributing to this increase in popularity of digital patient portals, including the surge in telemedicine needs following the COVID-19 pandemic, technological advances enabling better integration of mobile-based health platforms, as

Clinical Trials 52

Clinical Trials Clinical Research Trials Hospitals 52

Agency IQ

FEBRUARY 23, 2024

BY CHELSEY MCINTYRE, PHARMD , KARI OAKES In a series of broad-ranging, frank discussions, attendees at a joint FDA-American Association of Cancer Research (AACR) workshop worked through opportunities and challenges for dose optimization across the span of cancer drug development activities. On the first day, discussants looked at how to tackle first-in human trials, weighed the importance of the maximum tolerated dose, and looked at the evolving concept of the clinical utility index.

FDA 59

FDA Drug Development Trials Research 59

Broad Institute

FEBRUARY 23, 2024

Healthy Engagement in Autism Research Dialogue (HEARD) By Rose Circeo February 23, 2024 Breadcrumb Home Healthy Engagement in Autism Research Dialogue (HEARD) There are currently a number of sensitive issues and concerns related to research, language usage and treatment of autistic individuals. This has led to disagreement and contention between groups within the autism community.

Research 52

Research Science Treatment 52

Agency IQ

FEBRUARY 23, 2024

BY WALKER LIVINGSTON, ESQ California state Sen. NANCY SKINNER has updated a bill she introduced in early January 2024 to ban the sale of intentionally added PFAS in the state after 2030. Although the bill may receive state support, the actual implementation of the ban, if passed, would be a herculean task. Fill out the form to read the full article.

59

59

Perficient: Drug Development

FEBRUARY 23, 2024

Universal design is not just about creating accessible spaces; it’s about crafting experiences that cater to the diverse needs of individuals. At the heart of this philosophy lies a user-centric approach—one that places the preferences, abilities, and feedback of users at the forefront of the design process. This blog post explores the transformative impact of adopting a user-centric approach in the pursuit of universal design.

Production 52

Production 52

Agency IQ

FEBRUARY 23, 2024

BY RACHEL COE, MSC This week, the FDA revised its guidance on assessing symptoms in outpatients in clinical trials for products intended to treat or prevent Covid-19. This update – the first since its initial publication in almost four years – reflects the significant gains in knowledge that have occurred in that timeframe. With this publication, the FDA has only one remaining Covid-19-related guidance document that still awaits revisions.

Clinical Trials 59

Clinical Trials FDA Trials Production 59

thought leadership

FEBRUARY 23, 2024

Discover the different types of formal FDA meetings for sponsors and applications including what to expect at each of these FDA meeting types.

FDA 52

FDA Production Science 52

Agency IQ

FEBRUARY 23, 2024

Workshop addresses oncology dose optimization across full span of development In a series of broad-ranging, frank discussions, attendees at a joint FDA-American Association of Cancer Research (AACR) workshop worked through opportunities and challenges for dose optimization across the span of cancer drug development activities. On the first day, discussants looked at how to tackle first-in human trials, weighed the importance of the maximum tolerated dose, and looked at the evolving concept of th

Science 40

Science FDA Trials Clinical Pharmacology 40

Drug & Device Law

FEBRUARY 23, 2024

The MDL and state court proceedings involving saxagliptin-based diabetes drugs (such as Onglyza and Kombiglyze) strike us as the mass tort that never should have been. These proceedings initially followed a familiar model—a publication identified a signal of a risk (albeit an exceptionally weak signal), and plaintiffs’ lawyers took their cue to collect their inventories in the usual ways and file lawsuits.

Testimonials 105

Testimonials Hospitals International FDA 105